Study-related adverse events. by Benjamin R. Lewis (22279166)

“…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

Subjects:

PRISMA flowchart of the article selection process. by Renáta Kiss-Miki (20760127)

Subjects:

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the mean difference of global IQ level among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the odds of 5-year overall-survival rate among children with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Data_table_with_all_identified_articles_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of grade 3 anemia (=event) among pediatric patients with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

“…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

Overview of the WeARTolerance program. by Ana Beato (20489933)

“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)